The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4'-(ethylsulfonyl)-2'-methyl-5-(trifluoromethyl)biphenyl-2-yloxy)acetic acid ID: ALA1778639
PubChem CID: 53359023
Max Phase: Preclinical
Molecular Formula: C18H17F3O5S
Molecular Weight: 402.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCS(=O)(=O)c1ccc(-c2cc(C(F)(F)F)ccc2OCC(=O)O)c(C)c1
Standard InChI: InChI=1S/C18H17F3O5S/c1-3-27(24,25)13-5-6-14(11(2)8-13)15-9-12(18(19,20)21)4-7-16(15)26-10-17(22)23/h4-9H,3,10H2,1-2H3,(H,22,23)
Standard InChI Key: KDOSMMYSHYZFQE-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
-0.8750 -11.3917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.4583 -12.1083 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.0460 -11.3892 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.7306 -13.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7318 -14.6023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0169 -15.0152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3005 -14.6019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3034 -13.7713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0187 -13.3622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5904 -13.3561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8772 -13.7690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1648 -13.3545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1674 -12.5286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8885 -12.1190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5979 -12.5358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0212 -12.5372 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.3080 -12.1226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3104 -11.2976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -10.8829 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0261 -10.8872 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0171 -15.8402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3028 -16.2529 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-4.7317 -16.2525 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-4.0250 -16.6625 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.2615 -12.5213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9748 -12.1069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8763 -14.5940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13 14 1 0
7 8 1 0
14 15 2 0
15 10 1 0
4 5 2 0
9 16 1 0
8 9 2 0
16 17 1 0
9 4 1 0
17 18 1 0
3 2 2 0
18 19 1 0
8 10 1 0
18 20 2 0
5 6 1 0
6 21 1 0
10 11 2 0
21 22 1 0
21 23 1 0
11 12 1 0
21 24 1 0
13 2 1 0
6 7 2 0
2 25 1 0
12 13 2 0
25 26 1 0
2 1 2 0
11 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 402.39Molecular Weight (Monoisotopic): 402.0749AlogP: 3.94#Rotatable Bonds: 6Polar Surface Area: 80.67Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.57CX Basic pKa: ┄CX LogP: 3.68CX LogD: 0.33Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.79Np Likeness Score: -1.29
References 1. Luker T, Bonnert R, Schmidt J, Sargent C, Paine SW, Thom S, Pairaudeau G, Patel A, Mohammed R, Akam E, Dougall I, Davis AM, Abbott P, Brough S, Millichip I, McInally T.. (2011) Switching between agonists and antagonists at CRTh2 in a series of highly potent and selective biaryl phenoxyacetic acids., 21 (12): [PMID:21592791 ] [10.1016/j.bmcl.2011.04.101 ] 2. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds, [10.6019/CHEMBL3301361 ]